Risk factors for major bleeding among patients with chronic kidney disease treated with acetylsalicylic acid.
慢性腎病患者使用 acetylsalicylic acid 的重大出血風險因素。
Kidney Blood Press Res 2024-11-11
Anticoagulation in patients with end-stage kidney disease and atrial fibrillation: a national population-based study.
末期腎病患者合併心房顫動的抗凝治療:一項全國人口基礎研究。
Clin Kidney J 2024-03-02
One- Versus Three-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease.
慢性腎臟疾病高出血風險患者中一個月對比三個月的雙抗血小板治療。
Am J Cardiol 2024-06-13
Risk factors for major bleeding in patients with atrial fibrillation and CKD G3-G5D on oral anticoagulants.
心房顫動及 CKD G3-G5D 患者使用口服抗凝劑的重大出血風險因素。
Clin Kidney J 2024-10-18
Risk factors for venous thromboembolism in patients with chronic kidney disease: a systematic review and meta-analysis.
慢性腎病患者靜脈血栓栓塞的風險因素:系統性回顧與統合分析。
Ren Fail 2024-11-25
Efficacy and safety of novel anticoagulant therapies in patients with chronic kidney disease-a systematic review and meta-analysis.
慢性腎病患者新型抗凝療法的療效與安全性——系統性回顧與荟萃分析。
J Nephrol 2024-11-29
Use of Aspirin and Initial Cardiovascular and Bleeding Risk in Patients with Chronic Kidney Disease.
慢性腎病患者中阿斯匹林的使用與初始心血管及出血風險。
Clin J Am Soc Nephrol 2025-03-14
Quantifying the potential contribution of drugs to the occurrence of acute kidney injury in patients with chronic kidney disease.
量化藥物對慢性腎病患者急性腎損傷發生的潛在貢獻。
Clin Kidney J 2025-01-09